Is it possible to combine the hormonal contraception and preconceptional planning?

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Kuznetsova I.V.

Is it possible to combine the hormonal contraception and preconceptional planning?

Authors:

Kuznetsova I.V.

More about the authors

Journal: Russian Journal of Human Reproduction. 2013;(1): 21‑25

Read: 2924 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kuznetsova IV. Is it possible to combine the hormonal contraception and preconceptional planning? Russian Journal of Human Reproduction. 2013;(1):21‑25. (In Russ.)

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Ozone therapy in pregravidar preparation for the application of assisted reproductive technology programs. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):67-74

Abstract:

Authors:

Kuznetsova I.V.

Close metadata

References:

Serov V.N., Prilepskaya V.N., Ovsyannikova T.V. Ginekologicheskaya endokrinologiya. M 2006; 252-284.
Waesthoff C.L., Heartwell S., Edwards S. et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol 2007; 196: 4: 412.
Cronin M., Schellschmidt I., Dinger J. Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives. Obstet Gynecol 2009; 114: 3: 616-622.
Barnhart K.T., Schreiber C.A. Return to fertility following discontinuation of oral contraceptives. Fertil Steril 2009; 91: 3: 569-663.
Brown J. Pitanie v techenie zhiznennogo tsikla (3-e izd.). Thomson Wadsworth 2008; 109-110.
Wald N.J. Folic acid and the prevention of neural-tube defects. Lancet 2004; 350: 101-103.
Furness D.L.F., Yasin N., Dekker G.A. et al. Maternal red cell folate concentration at 10-12 weeks gestation and pregnancy outcome. J Matern Fetal Neonatal Med 2011; 1-5.
Hankey G.J., Eikelboom J.W., Ho W.K., Bockxmeer F.M. Clinical usefulness of plasma homocystein in vascular disease. Med J Aust 2004; 181: 314-318.
Laanpere M., Altmäe S., Kaart T. et al. Folate-metabolizing gene variants and pregnancy outcome of IVF. Reprod BioMed Online 2011; 22: 603-614.
Bukowski R., Malone F.D., Porter F.T. et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med 2009; 6: e1000061.
Yen and Jaffe`s reproductive endocrinology: physiology, pathophysiology, and clinical management. Ed J.F. Strauss III, R.L. Barbieri. 5th ed.
Orjuela M.A., Cabrera-Muñoz L., Paul L. et al. Risk of retinoblastoma is associated with a maternal polymorphism in dihydrofolatereductase (DHFR) and prenatal folic acid intake. Cancer 2012; published online wileyonlinelibrary.com.
De-Regil L.M., Fernandez-Gaxiola A.C., Dowswell T., Pena-Rosas J.P. Effects and safety of periconceptional folat supplementation for preventing birth defects. Cochrane Database System Rev 2010, Is.10, CD007950. DOI:10.1002/114651858.CD007950.pub2.
Reckelhoff J.F. Basic research into the mechanisms responsible for postmenopausal hypertension. Int J Clin Pract 2004; 58: Suppl 139: 13-19.
Rapkin A.J., Winer S.A. Drospirenone: a novel progestin. Exp Opin Pharmacoter 2007; 8: 989-999.
Seeger H., Wallwiener D., Mueck A.O. Effects of drospirenone on cardiovascular markers in human aortic endothelial cells. Climacteric 2009; 12: 80-87

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.